| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/12/2008 | WO2008070344A2 Compositions and methods for binding sphingosine-1-phosphate |
| 06/12/2008 | WO2008070332A2 Feline influenza vaccine and method of use |
| 06/12/2008 | WO2008070284A2 Amyloid beta peptides and methods of uses thereof |
| 06/12/2008 | WO2008070137A2 Interferon alpha-induced pharmacodynamic markers |
| 06/12/2008 | WO2008070135A2 Methods of treating systemic lupus erythematosus |
| 06/12/2008 | WO2008070090A2 Compositions and methods for diagnosing and treating cancer |
| 06/12/2008 | WO2008070070A1 Inhibition of osteopontin for treatment of relapsing autoimmnune disease |
| 06/12/2008 | WO2008070047A2 Immunogens in cancer stem cells |
| 06/12/2008 | WO2008070042A2 High potency recombinant antibodies, methods for producing them and use in cancer therapy |
| 06/12/2008 | WO2008069999A2 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases |
| 06/12/2008 | WO2008069671A1 Transcription factor for killer cell activation, differentiation and uses thereof |
| 06/12/2008 | WO2008069663A1 Use of a varicellovirus tap-inhibitor for the induction of tumor- or virus-specific immunity against teipp |
| 06/12/2008 | WO2008068827A1 Kidney-specific novel organic ion transporter |
| 06/12/2008 | WO2008068631A2 Vaccines including antigen from four strains of influenza virus |
| 06/12/2008 | WO2008068481A1 New compounds, methods and uses |
| 06/12/2008 | WO2008068048A2 A novel passive vaccine for candida infections |
| 06/12/2008 | WO2008068017A1 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles |
| 06/12/2008 | WO2008067995A2 Means and method for raising improved immune response |
| 06/12/2008 | WO2008067651A1 Gender selection with the use of antibodies |
| 06/12/2008 | WO2008052030A3 A method for increasing antibody-dependent cytotoxicity with castanospermine |
| 06/12/2008 | WO2008047134A3 Antibody molecules which bind il-17a and il-17f |
| 06/12/2008 | WO2008039171A3 Inactivating pathogens with hydrogen peroxide for vaccine production |
| 06/12/2008 | WO2008028686A3 Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 06/12/2008 | WO2008026071A3 Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying hpv antigens |
| 06/12/2008 | WO2008025964A3 Antibodies to an epitope of agr2. assays and hybridomas |
| 06/12/2008 | WO2008020596A3 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 06/12/2008 | WO2007143098A3 Hepatocyte growth factor (hgf) binding proteins |
| 06/12/2008 | WO2007132338A3 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 06/12/2008 | WO2007087370A3 Tat-038 and methods of assessing and treating cancer |
| 06/12/2008 | WO2007068895A9 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 06/12/2008 | WO2005046434A8 Compositions and methods for diagnosing and treating mental disorders |
| 06/12/2008 | US20080139815 Drug conjugates |
| 06/12/2008 | US20080139783 Compositions and methods for detecting treponema pallidum |
| 06/12/2008 | US20080139494 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139400 Molecular display on multimeric protein scaffolds |
| 06/12/2008 | US20080138894 Recombinant expression in eukaryotic or mammalian cells using vectors; cleavage and site-directed mutagenesis |
| 06/12/2008 | US20080138892 Rodent hepatitis viral nucleocapsids/core antigens for use as multivalent carrier platforms for enhancing the immune response to weak haptenic-like antigens |
| 06/12/2008 | US20080138431 Microparticle; poly-lactide biodegradable polymer; polyuridylic acid immunogenic single-stranded ribonucleic acid; recombinant Protective Antigen of Bacillus anthracis biologically active macromolecule; cationic polymer or cationic lipid stabilizing agent; mucosal administration via inhaler; parenteral |
| 06/12/2008 | US20080138419 Method for preparing an orally administrable formulation for controlled release |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138365 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 06/12/2008 | US20080138364 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 06/12/2008 | US20080138363 Attenuated Chimeric Flavivirus Bearing Attenuated Japanese Encephalitis Virus Gene as Backbone |
| 06/12/2008 | US20080138362 Cell Strain Capable of Being Cultured Without Ingredients Derived From Animals, Method of Producing the Same, Method of Producing Virus Using the Same, and Method of Producing Vaccine |
| 06/12/2008 | US20080138361 By virus-like proteins; transforming, culturing and isolating the recombinant yeast; immunotherapy of human papillomavirus-associated cancer |
| 06/12/2008 | US20080138360 A combined vaccine with immunization schedules that combine prime doses with DNA vaccine and booster doses either with proteins or recombinant viral vectors; chronic hepatitis C, cirrhosis and liver cancer |
| 06/12/2008 | US20080138359 Neisseria meningitidis lgtb Los as Adjuvant |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |
| 06/12/2008 | US20080138357 Vaccines Against Neisseria Meningitidis |
| 06/12/2008 | US20080138356 Pili from Mycobacterium Tuberculosis |
| 06/12/2008 | US20080138355 Modified leukotoxin gene and protein |
| 06/12/2008 | US20080138354 Adeno-associated viral vector comprising nucleic acids coding modified nuclear localization signal sequences for use in vaccination against viral infection; genetic vaccines |
| 06/12/2008 | US20080138353 Alpha b-chrystallin as a therapy for inflammation |
| 06/12/2008 | US20080138352 Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases |
| 06/12/2008 | US20080138351 Liposome treatment of viral infections |
| 06/12/2008 | US20080138350 Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery |
| 06/12/2008 | US20080138349 Using variation in FC gamma receptor as therapeutic tool in treatment and prevention of infection, inflammatory, autoimmune and cell proliferative diseases |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138346 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | US20080138344 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same |
| 06/12/2008 | US20080138343 Immunoglobulin for use in prevention and treatment of CD70 expressing cell proliferative disorders; immunosuppressant |
| 06/12/2008 | US20080138342 Using immunoglobulin specific to vascular endothelial growth factor receptor (Flt-1) as therapeutic tool in treatment toxemia in late pregnancy |
| 06/12/2008 | US20080138341 Anti-CD70 antibody and its use for the treatment of cancer and immune disorders |
| 06/12/2008 | US20080138340 Methods and compositions for modulating the immune system of animals |
| 06/12/2008 | US20080138339 Anti human ovarian cancer-anti CD3 bispecific antibody |
| 06/12/2008 | US20080138338 Polypeptide variants |
| 06/12/2008 | US20080138337 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 06/12/2008 | US20080138336 Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease |
| 06/12/2008 | US20080138335 Stabilized Human IgG2 And IgG3 Antibodies |
| 06/12/2008 | US20080138334 Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138332 Methods and Compositions for the Treatment and Prevention of Staphylococcus Aureus Infections Through Interference With OPUC Operon Interaction with TRAP |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | US20080138330 Methods and Compositions for Treating Conditions Involving Abnormal Angiogenesis |
| 06/12/2008 | US20080138318 Compositions Comprising Viruses and Methods for Concentrating Virus Preparations |
| 06/12/2008 | US20080138280 Composition and Methods For Inhibiting Cell Survival |
| 06/12/2008 | US20080138277 Drug delivery of therapeutic agent and carrier comprising targeting moiety that interacts with a target molecule such as chemokines, interferons, interleukins, osteoponting, chaperone proteins, receptors, and cellular adhesion molecules present in atherosclerotic lesions in blood vessels; diagnosis |
| 06/12/2008 | US20080138276 Monoclonal antibody produced by hybridoma with IDAC accession number 180706-02; competitive binding of monoclonal antibody, humanized-, chimeric- or cancerous disease modifying antibodies (CDMAB) with tissue sample induces cytotoxicity; anticarcinogenic, antitumor, and antimetastasis agents; diagnosis |
| 06/12/2008 | US20080138275 Hybridoma cell line G250 and its use for producing monoclonal antibodies |
| 06/12/2008 | CA2699837A1 Variant target binding agents and uses thereof |
| 06/12/2008 | CA2672120A1 Antagonistic antibodies against ephb3 |
| 06/12/2008 | CA2672052A1 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles |
| 06/12/2008 | CA2671629A1 Vaccines including antigen from four strains of influenza virus |
| 06/12/2008 | CA2671571A1 High protein concentration formulations containing mannitol |
| 06/12/2008 | CA2671492A1 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 06/12/2008 | CA2671457A1 Human antibodies that bind cd22 and uses thereof |
| 06/12/2008 | CA2671410A1 Peptide and treatment for hiv-1 infection |
| 06/12/2008 | CA2670897A1 Methods of treating systemic lupus erythematosus |
| 06/12/2008 | CA2670594A1 Interferon alpha-induced pharmacodynamic markers |
| 06/12/2008 | CA2669735A1 Methods of treating hemolytic anemia |
| 06/12/2008 | CA2668942A1 Means and method for raising improved immune response |
| 06/12/2008 | CA2667574A1 Compositions and methods for binding sphingosine-1-phosphate |
| 06/12/2008 | CA2667454A1 Feline influenza vaccine and method of use |
| 06/11/2008 | EP1930728A1 Use of the mal protein as a tumour marker |
| 06/11/2008 | EP1930438A1 Transcription factor for killer cell activation, differentiation and uses thereof |
| 06/11/2008 | EP1930427A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 06/11/2008 | EP1930414A1 Method for activation treatment of antigen-presenting cell |